Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

59.74
+0.98001.67%
Post-market: 60.650.9130+1.53%19:58 EDT
Volume:2.72M
Turnover:163.43M
Market Cap:9.93B
PE:-17.17
High:60.92
Open:59.64
Low:59.06
Close:58.76
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.15
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:22.58
PE(LYR):-25.09

Loading ...

Needham Adjusts Ionis Pharmaceuticals Price Target to $86 From $105, Maintains Buy Rating

MT Newswires Live
·
Jul 10

Alnylam, Bridgebio Gain from Astrazeneca-ionis Drug Missing Target

Dow Jones
·
Jul 10

Uk's FTSE 100 Ticks Lower as Astrazeneca Drag Offsets Banks, Mining Gains

Reuters
·
Jul 10

Top Midday Stories: Tensions Rise as US, Iran Trade Attacks; Micron to Invest $3 Billion in US Semiconductor Supply Chain

MT Newswires Live
·
Jul 09

Ionis Pharmaceuticals price target lowered to $87 from $104 at Raymond James

TIPRANKS
·
Jul 09

Ionis Pharmaceuticals Inc : TD Cowen Cuts Target Price to $94 from $108

THOMSON REUTERS
·
Jul 09

AstraZeneca PLC Stock (AZN) Moved Down by 6.72% on Jul 9: A Full Analysis

TradingKey
·
Jul 09

Lumentum, Applied Materials, Corning, Astrazeneca, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 09

Movement Alert|Ionis Pharmaceuticals Falls 20.03% in Regular Trading, Core Pipeline Drug Eplontersen Fails Phase 3 Cardiac Trial Primary Endpoint

Market Focus
·
Jul 09

Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results

TIPRANKS
·
Jul 09

Ionis Pharmaceuticals falls -17.6%

TIPRANKS
·
Jul 09

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday as Chip Stocks Rebound Despite US-Iran Tensions

MT Newswires Live
·
Jul 09

Astrazeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction

Dow Jones
·
Jul 09

Ionis Pharmaceuticals Shares Sink After Late-stage Trial Failed to Meet Primary Goal

Dow Jones
·
Jul 09

U.S. Stocks on the Move-levi, Ionis Pharmaceuticals, Gloo Holdings

Reuters
·
Jul 09

S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, Bridgebio Pharma Lead

Dow Jones
·
Jul 09

Schwab Strategists Warn of a Major Market Shift: the Era of Easy Index Gains is Officially Over.

Dow Jones
·
Jul 09

Major Drugmaker Loses $27 Billion in Market Value After Failed Trial

Dow Jones
·
Jul 09

AstraZeneca says CARDIO-TTRansform trial did not meet primary efficacy endpoint

TIPRANKS
·
Jul 09

Tech Rebound Lifts European Shares After Three-day Slide

Reuters
·
Jul 09